SCHEMBL6284703

SCHEMBL6284703

CC(C)CCCc1ccccc1N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.39
SLC6A2 P23975 2/20 0.39
SLC6A4 P31645 2/20 0.39
SLC6A3 Q01959 2/20 0.39
CYP3A4 P08684 1/20 0.35
ALOX15 P16050 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
AOC3 Q16853 1/20 0.34
FDPS P14324 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
TAAR1 Q96RJ0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL104783 0.88 SLC6A2 (0.46) SIGMAR1SLC6A2SLC6A4SLC6A3CYP3A4
SCHEMBL7637846 0.85 SLC6A2 (0.41) SLC6A2SLC6A4SLC6A3AOC3MEN1
SCHEMBL8468011 0.85 SIGMAR1 (0.37) SIGMAR1SLC6A2SLC6A4SLC6A3CYP3A4
SCHEMBL29922786 0.85 CD44 (0.38) SLC6A2SLC6A4SLC6A3CYP3A4TDP1
SCHEMBL10606666 0.83 SIGMAR1 (0.36) SIGMAR1SLC6A2SLC6A4SLC6A3CYP3A4
SCHEMBL8702413 0.82 SIGMAR1 (0.36) SIGMAR1SLC6A2SLC6A4SLC6A3CYP3A4
SCHEMBL23159850 0.80 ALOX15 (0.47) SIGMAR1CYP3A4ALOX15CASP1CASP7
SCHEMBL23159894 0.80 ALOX15 (0.47) SIGMAR1CYP3A4ALOX15CASP1CASP7
SCHEMBL29133246 0.79 LTB4R (0.47) SIGMAR1
SCHEMBL7637528 0.79 HIF1A (0.41) SLC6A2SLC6A4SLC6A3MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116390981-A Use of eugenol derivatives as stabilizers, organic materials and eugenol derivatives 弗劳恩霍夫应用研究促进协会 2023-07-04 CN disclosed
CN-116368185-A Use of dehydrobisphenol, eugenol oligomers and/or eugenol polymers for stabilizing organic materials, stabilized plastic compositions, stabilizer compositions and method for stabilizing organic materials 弗劳恩霍夫应用研究促进协会 2023-06-30 CN disclosed
US-6919291-B2 Fluorinated zwitterionic cocatalyst activators for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2005-07-19 US disclosed
US-20040110631-A1 Fluorinated zwitterionic cocatalyst activators for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2004-06-10 US disclosed
EP-1349653-A2 FLUORINATED ZWITTERIONIC COCATALYST ACTIVATORS FOR OLEFIN POLYMERIZATION ExxonMobil Chemical Patents Inc. (US) 2003-10-08 EP disclosed
WO-2002036639-A2 FLUORINATED ZWITTERIONIC COCATALYST ACTIVATORS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2002-05-10 WO disclosed
EP-0822958-A1 HALOGENATED ELASTOMER COMPOSITIONS MONSANTO COMPANY (US) 1998-02-11 EP disclosed
WO-1996034043-A1 HALOGENATED ELASTOMER COMPOSITIONS MONSANTO COMPANY (US) 1996-10-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110631-A1 Fluorinated zwitterionic cocatalyst activators for olefin polymerization FZD7, FOS, COG4 SIGMAR1 2026/4885SLC6A2 3376/4885SLC6A4 1434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.